StonvexLoading…
StonvexStonvexStonvexCore line items from ALNY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $1.35B | $3.71B | $2.62B | $1.37B | $594.19M |
Operating Income | Not available | $501.58M | $369.86M | $1.88M | $18.08M |
Net Income | Not available | $313.75M | $202.20M | $-90.48M | $-18.25M |
EPS (Diluted) | $1.63 | $2.33 | $1.51 | $-0.70 | $-0.14 |
Total Assets | Not available | $4.97B | $4.85B | $4.57B | $4.21B |
Total Liabilities | Not available | $4.18B | $4.62B | $4.32B | $4.10B |
Cash & Equivalents | Not available | $1.66B | $1.49B | $1.11B | $1.02B |
Free Cash Flow OCF − CapEx | Not available | $465.38M | $325.12M | $12.15M | $-127.28M |
Shares Outstanding | Not available | 132.38M | 131.79M | 130.98M | 130.31M |